|
|
580 Middletown Boulevard, #D-150
Langhorne, PA 19047 USA
phone:267-212-1100
fax:267-212-1101
|
|
| Symbol |
Private |
| Founded |
2003 |
| Employees |
|
|
|
| www.micromri.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| High Resolution MRI for Visualization of Bone Microarchitecture. |
|
| Management |
| Andreas Muehler, President & Chief Executive Officer; Michael Kleerekoper, Chief Medical Officer; Bob Sohval, Chief Technology Officer; Charles Cahn, JR., Chairman; Robert Peterhans, Directors |
| |
|
|
| |
|
| Keywords |
| microscopic, absorptiometry, acquisition, anthropomorphic, immobilization |
|
|
|
| Description |
|
MicroMRI, Inc. is a medical device company focused on developing and commercializing novel and innovative products that perform high resolution Magnetic Resonance Imaging (MRI) of bone micro-architecture with subsequent detailed visualization of bone structural elements. The Company intends to develop a commercial product for routine clinical use that can be deployed as an add-on to currently available clinical MRI scanners.
It is the mission of MicroMRI to become the premier company for non-invasive visualization of bone micro-architecture.
Until recently, MRI as a modality had not been used for bone imaging because of technical limitations regarding signal and resolution. The technology originally developed at University of Pennsylvania has overcome these limitations and allowed for the first time the visualization of bone micro-architecture using high-signal, high resolution MRI. Since our founding in 2003 with a license to the technology from the University of Pennsylvania, MicroMRI has been steadily developing its proprietary post-processing software. In 2004 the Company won a $4M NIH SBIR grant to investigate the performance of our technology in a multicenter clinical trial. The Company has also executed contracts with several pharmaceutical companies to use its technology for contract research services during pharmaceutical industry sponsored clinical trials investigating new drug treatments. To date, more than 19 scientific papers have been published and multiple site initiated grants have been funded, highlighting the broad potential of the technology. |
|
| Products / Services |
The VBB system.
|
|
| Technology / Differentiation |
| MicroMRI’s technology is currently available for investigational use, as an ‘add-on’ to whole-body MRI scanners at both, 1.5T and 3T field strength, and for dedicated musculoskeletal scanners at 1.0T field strength. |
|
| Market / Customers |
Until it is approved the use of VBB is strickly limited to scientific research puposes and it cannot be used in anay way to diagnose disease nor to follow recommend therapy.
|
|
| Strategy |
MicroMRI aims to pursue FDA approval and launch its suite of products in clinical markets in the U.S. and elsewhere.
|
|
| Funding |
| MicroMRI is funded by NIH grants, private funding, and customers who utilize its technologies for clinical and academic research. MicroMRI is currently conducting multiple clinical trials. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members